Morgan Hakki

Associate Professor

  • 1088 Citations
  • 14 h-Index
19952019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Morgan Hakki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Cytomegalovirus Medicine & Life Sciences
Cytomegalovirus Infections Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Human herpesvirus 5 Agriculture & Biology
Transplants Medicine & Life Sciences
Hematologic Neoplasms Medicine & Life Sciences
Pseudomonas aeruginosa Medicine & Life Sciences
Double-Stranded RNA Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2004 2009

RNA-Binding Proteins
Cytomegalovirus
Double-Stranded RNA
Protein Kinases
Interferons

Research Output 1995 2019

  • 1088 Citations
  • 14 h-Index
  • 27 Article
  • 1 Chapter

Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients

Hakki, M., Humphries, R. M., Hemarajata, P., Tallman, G. B., Shields, R. K., Mettus, R. T., Doi, Y. & Lewis, J. S., May 30 2019, In : Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 68, 12, p. 2045-2052 8 p.

Research output: Contribution to journalArticle

meropenem
Fluoroquinolones
Hematologic Neoplasms
Pseudomonas aeruginosa
Transplants
1 Citation (Scopus)
Cell Transplantation
Graft vs Host Disease
Bacterial Infections
Gastrointestinal Tract
Incidence

Isavuconazole to prevent invasive fungal infection in immunocompromised adults: Initial experience at an academic medical centre

Bowen, C. D., Tallman, G. B., Hakki, M. & Lewis, J. S., Jan 1 2019, In : Mycoses.

Research output: Contribution to journalArticle

Drug Costs
Inpatients
Cost Savings
isavuconazole
Invasive Fungal Infections
2 Citations (Scopus)
Pseudomonas Infections
Hematologic Neoplasms
Pseudomonas aeruginosa
Transplants
Therapeutics
1 Citation (Scopus)

Assessment of a cytomegalovirus serology dual-testing strategy in hematopoietic stem cell transplant recipients

Perry, D. A. & Hakki, M., Oct 1 2016, In : Transplant Infectious Disease. 18, 5, p. 809-814 6 p.

Research output: Contribution to journalArticle

Red Cross
Hematopoietic Stem Cell Transplantation
Serology
Hematopoietic Stem Cells
Cytomegalovirus